Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 43

    1.

    Chronic eosinophilic leukemia with FIP1L1-PDGFRA.

    Verdu J, de Paz F.

    Blood. 2013 Feb 21;121(8):1254. No abstract available.

    PMID:
    23550302
    [PubMed - indexed for MEDLINE]
    2.

    No asthma, no parasites is a rare type of leukemia: chronic myeloid neoplasm with eosinophilia and abnormality of platelet-derived growth factor receptor alpha.

    Santiago-Casiano M, Alemán JR, Matos-Fernández NA, Cáceres-Perkins W, De La Paz M.

    Bol Asoc Med P R. 2012 Jul-Sep;104(3):41-6.

    PMID:
    23156891
    [PubMed - indexed for MEDLINE]
    3.

    World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.

    Gotlib J.

    Am J Hematol. 2012 Sep;87(9):903-14. doi: 10.1002/ajh.23293.

    PMID:
    22926771
    [PubMed - indexed for MEDLINE]
    4.

    Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia.

    Lierman E, Selleslag D, Smits S, Billiet J, Vandenberghe P.

    Blood. 2012 Aug 16;120(7):1529-31. doi: 10.1182/blood-2012-06-433821. No abstract available.

    PMID:
    22899477
    [PubMed - indexed for MEDLINE]
    5.

    Response to imatinib mesylate in patients with hypereosinophilic syndrome.

    Arefi M, García JL, Briz MM, de Arriba F, Rodríguez JN, Martín-Núñez G, Martínez J, López J, Suárez JG, Moreno MJ, Merino MA, Gutiérrez NC, Hernández-Rivas JM.

    Int J Hematol. 2012 Sep;96(3):320-6. doi: 10.1007/s12185-012-1141-7. Epub 2012 Jul 18.

    PMID:
    22806436
    [PubMed - indexed for MEDLINE]
    6.

    Chronic eosinophilic leukemia presenting with mouth and penile ulcers.

    Najera JE, Harn L.

    Am J Med. 2012 Aug;125(8):e5-6. doi: 10.1016/j.amjmed.2011.11.017. Epub 2012 Jun 7. No abstract available.

    PMID:
    22681908
    [PubMed - indexed for MEDLINE]
    7.

    Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL.

    Li B, Zhang G, Li C, He D, Li X, Zhang C, Tang F, Deng X, Lu J, Tang Y, Li R, Chen Z, Duan C.

    PLoS One. 2012;7(4):e34912. doi: 10.1371/journal.pone.0034912. Epub 2012 Apr 16.

    PMID:
    22523564
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation.

    Helbig G, Soja A, Bartkowska-Chrobok A, Kyrcz-Krzemień S.

    Am J Hematol. 2012 Jun;87(6):643-5. doi: 10.1002/ajh.23193. Epub 2012 Mar 31.

    PMID:
    22473587
    [PubMed - indexed for MEDLINE]
    9.

    Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders.

    Gotlib J, Akin C.

    Semin Hematol. 2012 Apr;49(2):128-37. doi: 10.1053/j.seminhematol.2012.01.007. Review.

    PMID:
    22449623
    [PubMed - indexed for MEDLINE]
    10.

    Eosinophilic myeloid disorders.

    Noel P.

    Semin Hematol. 2012 Apr;49(2):120-7. doi: 10.1053/j.seminhematol.2012.01.008. Review.

    PMID:
    22449622
    [PubMed - indexed for MEDLINE]
    11.

    Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model.

    Wicklein D, Ramos Leal N, Salamon J, Thamer M, Herrmann H, Valent P, Schumacher U, Ullrich S.

    PLoS One. 2012;7(2):e30567. doi: 10.1371/journal.pone.0030567. Epub 2012 Feb 14.

    PMID:
    22348015
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?

    Prochorec-Sobieszek M, Nasiłowska-Adamska B, Borg K, Kopeć I, Kos-Zakrzewska K, Juszczyński P, Warzocha K.

    Leuk Lymphoma. 2012 Sep;53(9):1824-7. doi: 10.3109/10428194.2012.661856. Epub 2012 Mar 13. No abstract available.

    PMID:
    22288769
    [PubMed - indexed for MEDLINE]
    13.

    Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression.

    Hudson SA, Herrmann H, Du J, Cox P, Haddad el-B, Butler B, Crocker PR, Ackerman SJ, Valent P, Bochner BS.

    J Clin Immunol. 2011 Dec;31(6):1045-53. doi: 10.1007/s10875-011-9589-4. Epub 2011 Sep 22.

    PMID:
    21938510
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    An imatinib-treated FIL1P1-PDGFRα chronic eosinophilic leukemia transforming to erythroid blast crisis: a case report.

    Papanikolaou X, Kotsopoulou M, Triantafillopoulou ID, Zoi A, Chatziantoniou V, Maltezas D, Mitsouli-Mentzikof C.

    Ann Hematol. 2012 May;91(5):785-7. doi: 10.1007/s00277-011-1312-2. Epub 2011 Sep 1. No abstract available.

    PMID:
    21881824
    [PubMed - indexed for MEDLINE]
    15.

    Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia.

    Awano N, Ryu T, Yoshimura N, Takazoe M, Kitamura S, Tanaka M.

    Intern Med. 2011;50(16):1741-5. Epub 2011 Aug 15.

    PMID:
    21841337
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation.

    Metzgeroth G, Erben P, Martin H, Mousset S, Teichmann M, Walz C, Klippstein T, Hochhaus A, Cross NC, Hofmann WK, Reiter A.

    Leukemia. 2012 Jan;26(1):162-4. doi: 10.1038/leu.2011.181. Epub 2011 Aug 5. No abstract available.

    PMID:
    21818111
    [PubMed - indexed for MEDLINE]
    17.

    Myeloprolipherative disorder type chronic myeloid leukemia--eosinophilic form.

    Arnautovic-Custovic A, Hasic S, Kopic E, Jahic A, Jovic S.

    Med Arh. 2011;65(3):173-5.

    PMID:
    21776882
    [PubMed - indexed for MEDLINE]
    18.

    World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.

    Gotlib J.

    Am J Hematol. 2011 Aug;86(8):677-88. doi: 10.1002/ajh.22062. Review.

    PMID:
    21761433
    [PubMed - indexed for MEDLINE]
    19.

    Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period.

    Kawano S, Kato J, Kawano N, Yoshimura Y, Masuyama H, Fukunaga T, Sato Y, Maruyama H, Mihara K, Ueda A, Toyoda K, Imamura T, Kitamura K.

    Intern Med. 2011;50(9):975-81. Epub 2011 May 1. Review.

    PMID:
    21532219
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Atypical myeloproliferative disorders in adults.

    Zachée P.

    Transfus Apher Sci. 2011 Apr;44(2):211-21. doi: 10.1016/j.transci.2011.01.017. Review.

    PMID:
    21402312
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk